Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients
NCT05963282
·
clinicaltrials.gov ↗
COMPLETED
Status
9870
Enrollment
INDUSTRY
Sponsor class
Conditions
de Novo Heart Failure
Sponsor
Novartis Pharmaceuticals